查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2032245

2026-2034年全球肺癌篩檢市場規模、佔有率、趨勢和成長分析報告

Global Lung Cancer Screening Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 151 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球肺癌篩檢市場預計將從2025年的45.7億美元成長至2034年的103.6億美元，2026年至2034年的複合年成長率（CAGR）為9.53%。該市場正經歷顯著成長，主要原因是肺癌發病率不斷上升以及人們對早期檢測的日益重視。肺癌仍然是全球癌症死亡的主要原因之一，而篩檢計畫對於提高存活率至關重要。影像技術的進步，特別是低劑量CT（LDCT）技術的進步，正在提高篩檢的準確性和可近性，進一步加速其在醫療保健系統中的普及應用。

關鍵成長要素包括人們對早期診斷益處的認知不斷提高、政府推廣癌症篩檢的措施以及診斷技術的進步。醫療機構正擴大實施針對高風險族群（例如吸菸者和有肺部疾病史者）的篩檢計畫。此外，人工智慧 (AI) 與影像分析的結合提高了診斷準確率並減少了假陽性結果，從而進一步推動了市場成長。

市場預計將受益於持續的研發和技術創新。非侵入性篩檢方法（例如生物標記檢測）的開發有望拓展篩檢選擇。在新興市場，由於醫療基礎設施的完善和公眾意識的提高，預計將出現顯著的成長機會。肺癌篩檢市場預計將穩定成長，因為早期檢測在癌症治療中仍發揮著至關重要的作用。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球肺癌篩檢市場：依癌症類型分類

  • 市場分析、洞察與預測
  • 非小細胞肺癌（NSCLC）
  • 小細胞肺癌

第5章 全球肺癌篩檢市場：依診斷類型分類

  • 市場分析、洞察與預測
  • 低劑量螺旋電腦斷層掃描
  • 胸部X光片

第6章 全球肺癌篩檢市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院和診所
  • 診斷中心

第7章 全球肺癌篩檢市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Koninklijke Philips NV
    • Siemens Healthineers AG
    • Canon Medical Systems Corporation
    • GE Healthcare
    • FUJIFILM Holdings Corporation
    • Medtronic
    • Nuance Communications Inc
    • Eon
    • PenRad Technologies Inc
    • Volpara Solutions Limited
簡介目錄
Product Code: VMR112112145

The global lung cancer screening market size is expected to reach USD 10.36 Billion in 2034 from USD 4.57 Billion in 2025, growing at a CAGR of 9.53 during 2026-2034.This market is experiencing significant growth due to the increasing prevalence of lung cancer and the growing emphasis on early detection. Lung cancer remains one of the leading causes of cancer-related deaths worldwide, making screening programs essential for improving survival rates. Advances in imaging technologies, particularly low-dose computed tomography (LDCT), have enhanced the accuracy and accessibility of screening, encouraging more widespread adoption across healthcare systems.

Major drivers include rising awareness about the benefits of early diagnosis, government initiatives promoting cancer screening, and advancements in diagnostic technologies. Healthcare providers are increasingly implementing screening programs for high-risk populations, such as smokers and individuals with a history of lung disease. Additionally, the integration of artificial intelligence in imaging analysis is improving diagnostic accuracy and reducing false positives, further supporting market growth.

Looking ahead, the market is expected to benefit from ongoing research and technological innovation. The development of non-invasive screening methods, such as biomarker-based tests, is likely to expand screening options. Emerging markets are anticipated to offer significant growth opportunities due to improving healthcare infrastructure and awareness. As early detection continues to play a critical role in cancer management, the lung cancer screening market is set for sustained growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Cancer Type

  • Non-small Cell Lung Cancer (NSCLC)
  • Small Cell Lung Cancer

By Diagnosis Type

  • Low Dose Spiral CT Scan
  • Chest X-ray

By End User

  • Hospitals & Clinics
  • Diagnostic Centers

COMPANIES PROFILED

  • Koninklijke Philips N.V., Siemens Healthineers AG, Canon Medical Systems Corporation, GE Healthcare, FUJIFILM Holdings Corporation, Medtronic, Nuance Communications Inc., Eon, PenRad Technologies Inc., Volpara Solutions Limited

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL LUNG CANCER SCREENING MARKET: BY CANCER TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Cancer Type
  • 4.2. Non-small Cell Lung Cancer (NSCLC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Small Cell Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LUNG CANCER SCREENING MARKET: BY DIAGNOSIS TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Diagnosis Type
  • 5.2. Low Dose Spiral CT Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Chest X-ray Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LUNG CANCER SCREENING MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL LUNG CANCER SCREENING MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Cancer Type
    • 7.2.2 By Diagnosis Type
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Cancer Type
    • 7.3.2 By Diagnosis Type
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Cancer Type
    • 7.4.2 By Diagnosis Type
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Cancer Type
    • 7.5.2 By Diagnosis Type
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Cancer Type
    • 7.6.2 By Diagnosis Type
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL LUNG CANCER SCREENING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Koninklijke Philips N.V
    • 9.2.2 Siemens Healthineers AG
    • 9.2.3 Canon Medical Systems Corporation
    • 9.2.4 GE Healthcare
    • 9.2.5 FUJIFILM Holdings Corporation
    • 9.2.6 Medtronic
    • 9.2.7 Nuance Communications Inc
    • 9.2.8 Eon
    • 9.2.9 PenRad Technologies Inc
    • 9.2.10 Volpara Solutions Limited